Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation

Hepatology

Volumn 51, Issue 3, 2010, Pages 788-795

  Griffiths, William J H ^a   Mayr, Roman ^b   McFarlane, Ian ^a   Hermann, Martin ^c   Halsall, David J ^a   Zoller, Heinz ^b   Cox, Timothy M ^d  

^a Department of Hepatology ^*  (United States)

^b Gastroenterology and Hepatology   (United States)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CELL SURFACE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOLOGY; EMBRYO; FEMALE; GENE; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IRON OVERLOAD; IRON TRANSPORT; KIDNEY CELL; MACROPHAGE; MALE; MOLECULAR MECHANICS; MUTANT; PATHOPHYSIOLOGY; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SLC40A1 GENE; WILD TYPE;

ADULT; AGED; CATION TRANSPORT PROTEINS; CELLS, CULTURED; FEMALE; HEMOCHROMATOSIS; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; YOUNG ADULT;

EID: 77950602774     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23377     Document Type: Article

References (22)

1. Griffiths WJ. Review article: the genetic basis of haemochromatosis. Aliment Pharmacol Ther 2007;26:331-342.
2. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-623.
3. Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, Breuning MH, etal.A mutation inSLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001;28:213-214.
4. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 2004;32:131-138.
5. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000;275:19906-19912.
6. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the ba-solateral transfer of iron to the circulation. Mol Cell 2000;5:299-309.
7. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000;403:776-781.
8. Knutson MD, Vafa MR, Haile DJ, Wessling-Resnick M. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 2003;102:4191-4197.
9. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 2002;29: 327-335.
10. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-2093.
11. DeDomenicoI,Ward DM, NemethE,Vaughn MB, MusciG,GanzT,et al. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci USA 2005;102:8955-8960.
12. Drakesmith H, Schimanski LM, Ormerod E, Merryweather-Clarke AT, Viprakasit V, Edwards JP, et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 2005;106: 1092-1097. (Pubitemid 41076459)
13. Zoller H, McFarlane I, Theurl I, Stadlmann S, Nemeth E, Oxley D, et al. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. HEPATOLOGY 2005;42:466-472.
14. Fernandes A, Preza GC, Phung Y, de Domenico I, Kaplan J, Ganz T, et al. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 2009;114:437-443.
15. Wallace DF, Pedersen P, Dixon JL, Stephenson P, Searle JW, Powell LW, et al. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood 2002;100:692-694.
16. Girelli D, De Domenico I, Bozzini C, Campostrini N, Busti F, Castagna A, et al. Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. J Hepatol 2008;49:664-671.
17. Koyama C, Wakusawa S, Hayashi H, Ueno T, Suzuki R, Yano M, et al. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low trans-ferrin saturation of iron. Intern Med 2005;44:990-993.
18. Jouanolle AM, Douabin-Gicquel V, Halimi C, Loreal O, Fergelot P, Delacour T, et al. Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload. J Hepatol 2003;39:286-289.
19. De Domenico I, Nemeth E, Nelson JM, Phillips JD, Ajioka RS, Kay MS, et al. The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab 2008;8:146-156.
20. De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI, et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 2007;18:2569-2578.
21. Rice AE, Mendez MJ, Hokanson CA, Rees DC, Björkman PJ. Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter. J Mol Biol 2009;386:717-732.
22. Liu XB, Yang F, Haile DJ. Functional consequences of ferroportin 1 mutations. Blood Cells Mol Dis 2005;35:33-46.